Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated January 20, 2023, titled "Dr. Reddy s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe".
Press Release Jan 20 2023
Filed with NSE · · 4 pages · English
Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Replay · Oct 23Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings CallRelease
Dr. Reddy's Laboratories Ltd. on 6ix
Earlier from Dr. Reddy's Laboratories
- Press Release Jan 13 2023
- Press Release Dec 19 2022
- Press Release Dec 16 2022
- Press Release Oct 11 2022
- Press Release Sep 07 2022
Later from Dr. Reddy's Laboratories
- Press Release Jan 27 2023
- Press Release Feb 08 2023
- Dr. Reddy's Laboratories Ltd. Press Release Feb 27 2023
- Press Release Mar 16 2023
- Press Release Apr 21 2023
Follow Dr. Reddy's Laboratories into a list and get an email when it puts out news.
Follow Dr. Reddy's Laboratories